Form 4 for AGL agilon health, inc.
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-05 · accession 0001628280-24-000958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-09 | 2024-01-05 | AGL | WILLIAMS RONALD A | Dir | M - OptEx | $1.27 | +1.10M | 3.41M | +48% | +$1.40M |
| DM | 2024-01-09 | 2024-01-05 | AGL | WILLIAMS RONALD A | Dir | M - OptEx | $0.00 | -1.10M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-05 | M | A | 150,000 | $3.00 | 3,564,414 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-05 | M | A | 950,000 | $1.00 | 3,414,414 | D | — | — | |
| 3 | Derivative | Options (Rights to Buy) | 2024-01-05 | M | D | 150,000 | $0.00 | 0 | D | $3.00 · — to 2027-04-27 | 150,000 Common Stock | (F2) These options were granted on April 27, 2017, and fully vested on September 14, 2021. |
| 4 | Derivative | Options (Rights to Buy) | 2024-01-05 | M | D | 950,000 | $0.00 | 0 | D | $1.00 · — to 2026-12-30 | 950,000 Common Stock | (F1) These options were granted on December 30, 2016, and fully vested on July 1, 2020. |